SEC Form 4 · accession 0001209191-17-059597

METLIFE INC · MET

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President, Asia

Period of report

Nov 3, 2017

Accepted (ET)

Nov 7, 2017 · 4:16 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001099219

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Nov 3, 2017	M	49,660	$27.19	A	49,660	D
Common Stock^F1,F2	Nov 3, 2017	S	49,660	$54.605	D	0	D
Common Stock	Nov 3, 2017	M	33,071	$31.15	A	33,071	D
Common Stock^F1,F3	Nov 3, 2017	S	33,071	$54.602	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F4	$27.19	Nov 3, 2017	M	49,660	D	—	Jul 31, 2022	Common Stock	49,660	0	D
Employee Stock Option (Right to Buy)^F5	$31.15	Nov 3, 2017	M	33,071	D	—	Feb 25, 2023	Common Stock	33,071	0	D

F1The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F2The shares were sold in multiple transactions at prices $54.560 to $54.630, inclusive.
F3The shares were sold in multiple transactions at prices $54.600 to $54.618, inclusive.
F4The options became exercisable in three equal installments on August 1, 2013, 2014 and 2015.
F5The options became exercisable in three equal installments on February 26, 2014, 2015 and 2016.